Recombinant human interferon α2b (Beijing Kawin Technology)

重组人干扰素α2b（北京凯因科技）

Report date: 2026/05/08 20:02:52

Base Information

Drug NameRecombinant human interferon α2b (Beijing Kawin Technology)
Drug Alias NameInterferon α-2b - Beijing Kawin Technology干扰素α-2b生物类似药 - 北京凯因科技Interferon alfa-2b - Beijing Kawin TechnologyInterferon alpha-2b (Beijing Kawin Technology)凯因益生 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasmsHerpanginaVirus Diseases +[5] 
Global Approved IndicationsNeoplasmsVirus Diseases
Approved Indications in ChinaNeoplasmsVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Kawin Technology Share-Holding Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Kawin Technology Share-Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasmsHerpanginaVirus Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A